U. Franke et al., Retrograde versus antegrade crystalloid cardioplegia in coronary surgery: Value of troponin-I measurement, ANN THORAC, 71(1), 2001, pp. 249-253
Citations number
22
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Background. The optimal route for delivery of cardioplegia is still in deba
te in patients with ischemic heart disease. Cardiac troponin-I is a new mar
ker with the potential for detection of minor differences in myocardial isc
hemia.
Methods. In a prospective randomized trial 58 patients undergoing elective
coronary artery bypass grafting for two- or three-vessel coronary artery di
sease were divided into groups with antegrade (group A, n = 29) and retrogr
ade (group R, n = 29) application of crystalloid cardioplegia (St. Thomas I
I). Patients with major risk factors were excluded. In addition to routine
electrocardiogram monitoring, cardiac troponin-I and creatine kinase-MB act
ivity were measured in all patients preoperatively at 2, 5, 8, 24, and 48 h
ours after aortic cross-clamp release, and at hospital discharge.
Results. In both groups, there were no differences regarding operative para
meters. A significantly higher cardiac troponin-I concentration was observe
d in the antegrade group at 24 hours after cross-clamp (8.2 +/- 8.5 mug/L v
s 3.2 +/- 3.1 mug/L; p = 0.02). Patients with subtotal stenosis or occlusio
n of one or more main coronary arteries showed significantly lower cardiac
troponin-I levels after retrograde application.
Conclusions. Lower concentrations of the cardiac troponin-I marker after re
trograde application of cardioplegia indicate advantages of myocardial prot
ection in ischemic heart disease.